Drug Trial Radar · NCT05548556
A Study to Evaluate RO7204239 in Participants With Facioscapulohumeral Muscular Dystrophy
Last checked: Nov 19, 2026Latest source record: Oct 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
51
Actual
Start
Feb 7, 2023
Primary completion
May 2, 2025
Study completion Oct 9, 2026
Sponsor
- Lead sponsor
- Hoffmann-La RocheRoche (Genentech) (RHHBY)
- Sponsor type
- Industry
- First posted
- Sep 21, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the pharmacodynamics, safety, tolerability, pharmacokinetics, and efficacy of RO7204239, a humanized monoclonal antibody that binds to human latent myostatin, in ambulant adult participants with facioscapulohumeral muscular dystrophy (FSHD).
Conditions
- Facioscapulohumeral Muscular Dystrophy (FSHD)
Interventions
PlaceboDrug
Participants will receive subcutaneous (SC) placebo every 4 weeks (Q4W)
RO7204239Drug
Participants will receive SC RO7204239 Q4W
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent change from baseline in contractile muscle volume (CMV) of quadriceps femoris muscles as assessed by magnetic resonance imaging (MRI) bilaterallyTime frame: Week 52
- Percentage of participants with adverse events (AEs)Time frame: Up to 2.5 years
Locations
9 sites in 4 countries. Site status is shown where the registry gives one.
University of Irvine Medical Center (UCIMC)
Orange, California
Regents of the University of Colorado
Aurora, Colorado
University of Kansas Medical Center
Fairway, Kansas
Kennedy Krieger Institute
Baltimore, Maryland
Rigshospitalet
København Ø, Denmark
Policlinico Universitario Agostino Gemelli
Rome, Lazio, Italy
Asst Grande Ospedale Metropolitano Niguarda
Milan, Lombardy, Italy
National Hospital for Neurology and Neurosurgery,
London, United Kingdom
Royal Victoria Infirmary
Newcastle upon Tyne, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.